Fossdal Ragnheidur, Jonasson Fridbert, Kristjansdottir Gudlaug T, Kong Augustine, Stefansson Hreinn, Gosh Shyamali, Gulcher Jeffrey R, Stefansson Kari
deCODE Genetics, IS-101 Reykjavik, Iceland.
Hum Mol Genet. 2004 May 1;13(9):975-81. doi: 10.1093/hmg/ddh106. Epub 2004 Mar 11.
Sveinsson's chorioretinal atrophy (SCRA), also referred to as helicoid peripapillary chorioretinal degeneration or atrophia areata, is an autosomal dominant eye disease, characterized by symmetrical lesions radiating from the optic disc involving the retina and the choroid. Genome-wide linkage analysis mapped the SCRA gene to chromosome 11p15 in 81 patients from a large founder pedigree in Iceland. The parametric LOD score obtained was 18.9 using an autosomal dominant model with high penetrance. Crossover analysis of the linkage region with 51 markers identified a 593 kb segment shared by all patients. Sequencing exons of the only gene in this interval, the transcriptional enhancer TEAD1, revealed a novel missense mutation (Y421H) carried by all patients and none of the 502 controls. The mutation is in a conserved amino acid sequence in the C terminal of the protein, a potential binding site for YAP65 one of TEAD1's cofactors that is expressed in human retina as well as TEAD1 based on RT-PCR experiments. Therefore, we conclude that the mutation in the TEAD1 gene is the cause of Sveinsson's chorioretinal atrophy.
斯韦恩松脉络膜视网膜萎缩(SCRA),也被称为螺旋状视乳头周围脉络膜视网膜变性或斑状萎缩,是一种常染色体显性眼病,其特征为从视盘发出的对称性病变,累及视网膜和脉络膜。全基因组连锁分析将SCRA基因定位于冰岛一个大型奠基者家系的81名患者的11号染色体p15区域。使用高外显率的常染色体显性模型获得的参数化对数优势分数为18.9。用51个标记对连锁区域进行交叉分析,确定了所有患者共有的一个593 kb片段。对该区间内唯一基因转录增强子TEAD1的外显子进行测序,发现所有患者均携带一个新的错义突变(Y421H),而502名对照者均无此突变。该突变位于蛋白质C末端的一个保守氨基酸序列中,根据逆转录聚合酶链反应实验,这是TEAD1的辅因子之一YAP65的一个潜在结合位点,YAP65在人类视网膜以及TEAD1中均有表达。因此,我们得出结论,TEAD1基因中的突变是斯韦恩松脉络膜视网膜萎缩的病因。